Aprogen Biologics(KR:003060)
₩1,181.00-14.00 (-1.17%)
KR:003060
Aprogen Biologics Revenue
₩1,181.00
At close:-14.00 (-1.17%)
Want to see KR:003060 full AI Analyst Report?
Aprogen Biologics (003060) Revenue
Aprogen Biologics Revenue
Aprogen Biologics had a revenue of 23.08B in the quarter ending Jun 30, 2026, with 6.75%. This bring the company's revenue in the last twelve months to 86.18B, Increased 10.49%. In the fiscal year ending Dec 31, 2025, Aprogen Biologics had annual revenue of 73.23B with 8.68% growth.
- Revenue (ttm)
- 86.18B
- Revenue Growth
- 17.80%
- P/S Ratio
- 0.48
- Revenue/Employee
- KRW 194,233,793
- Employees
- 377
- Market Cap
- KRW 35.43B
Revenue Chart
Aprogen Biologics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 73.23B | 5.85B | 8.68% |
| Dec 31, 2024 | 67.38B | -19.99B | -22.88% |
| Dec 31, 2023 | 87.36B | 22.17B | 34.01% |
| Dec 31, 2022 | 65.19B | 8.71B | 15.42% |
| Dec 31, 2021 | 56.48B | 3.16B | 5.93% |
| Dec 31, 2020 | 53.32B | 2.42B | 4.75% |
| Dec 31, 2019 | 50.90B | 5.51B | 12.13% |
| Dec 31, 2018 | 45.40B | -705.56M | -1.53% |
| Dec 31, 2017 | 46.10B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

